See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Food and Drug Administration (FDA) has approved a new drug for ...
For a patient having their wisdom teeth removed, the days after surgery can bring an important question: How much pain ...
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...
Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of ...
Publication strengthens the scientific rationale for PP353 as a precisely targeted, non-opioid treatment for patients with vertebrogenic Lumbar ...
Today, AFT Pharmaceuticals announced the U.S. launch of Combogesic®, a new FDA Approved, Non-Opioid, prescription-strength combination of acetaminophen and ibuprofen developed for adult patients (over ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat ...
Patients with rheumatic disease who use prescription opioids often experience disruptions in pain management during care transitions.
Due to the physical contact nature of their occupation, the elite athletes of the National Football League (NFL) often experience pain. However, an analysis of 2021 and 2022 data from the National ...
(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results